Biocompatibility is a key concern when assessing the potential health risks of materials like GO. The reduction process generally decreases the number of oxygen groups, which may result in lower cytotoxicity. However, studies have shown that reduced graphene oxide can still cause significant cell damage, oxidative stress, and inflammatory responses, depending on the degree of reduction and surface functionality.
